Combretastatin A-4 and its analogues as antineoplastic agents

Polish Journal of Chemistry

Volumn 78, Issue 3, 2004, Pages 323-341

  Dzierzbicka, K ^a   Kolodziejczyk A M ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Angiogenesis inhibitors; Antimitotic agents; Antineoplastic agent; Biological activity; Combretastatin A 4; Synthesis

Indexed keywords

ANTINEOPLASTIC AGENT; COMBRETASTATIN A4; PRODRUG;

ANTINEOPLASTIC ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; REVIEW;

EID: 1642542532     PISSN: 01375083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Folkman J., N. Engl. J. Med., 285, 1182 (1971).
2. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R. and Folkamn J., Cell, 88, 277 (1997).
3. Harris A.L., Lancet, 351, 1598 (1998).
4. Gourley M. and Williamson J.S., Curr. Pharmacol. Design, 6, 417 (2000).
5. Aiello L.P., Nature Med., 6, 379 (2000).
6. Liekens S., De Clercq E. and Neyts J., Biochemical Pharmacology, 61, 253 (2001).
7. Opolski A. and Wietrzyk J., Post. Hig. Med. Dośw., 55, 369 (2001).
8. th ed.; DeVita V.T., Jr, Hellman S., Rosenberg S.A., eds.: Lippincott-Raven: Philadelphia, pp. 467-483 (1997).
9. Iwasaki S., J. Pharmacol. Soc. Jpn., 118, 111 (1998).
10. Li Q., Sham H.L., Rosenberg S.H., Antimitotic Agents. In Annual Reports in Medicinal Chemistry; Doherty A.M., Ed.; Academic Press: San Diego, Vol. 34, pp. 139-148 (1999).
11. Shi Q., Chen K., Morris-Natschke S.L. and Lee K.H., Curr. Pharm. Des., 4, 219 (1998).
12. Jordan A., Hadfield J.A., Laurence N.J. and McGown A.T., Med. Chem. Rev., 18, 259 (1998).
13. Pettit G.R., Singh S.B., Niven M.L., Hamel E. and Schmidt J.M., J. of Natural Products, 50, 119 (1987).
14. Pettit G.R. and Singh S.B., Can. J. Chem., 65, 2390 (1987).
15. Pettit G.R., Singh S.B., Hamel E., Lin C.M., Alberts D.S. and Garcia-Kendall D., Experientia, 45, 209 (1989).
16. Pettit G.R., Singh S.B. and Cragg G.M., J. Org. Chem., 50, 3404 (1985).
17. Singh S.B. and Pettit G.R., J. Org. Chem., 54, 4105 (1989).
18. Pettit G.R., Singh S.B., Boyd M.R., Hamel E., Pettit R.K., Schmidt J.M. and Hogan F., J. Med. Chem., 38, 1666 (1995).
19. Ohsumi K., Nakagawa R., Fukuda Y., Hatanaka T., Morinaga Y., Nihei Y., Ohishi K., Suga Y., Akiyama Y. and Tsuji T., J. Med. Chem., 41, 3022 (1998).
20. Brown R.T., Fox B.W., Hadfield J.A., McGown A.T., Mayalarp S.P., Pettit G.R. and Woods J.A., J. Chem. Soc. Perkin Trans. I, 5, 577 (1995).
21. Woods J.A., Hadfield J.A., Pettit G.R., Fox B.W. and McGown A.T., Br. J. Cancer, 71, 705 (1995).
22. Bedford S.B., Quarterman C.P., Rathbone D.L., Slack J.A., Griffin B.J. and Stevens M.F.G., Bioorg. Med. Chem. Lett., 6, 157 (1996).
23. Pettit G.R., Temple C., Jr, Narayanan V.L., Varma R., Simpson M.J., Boyd M.R., Rener G.A. and Bansal N., Anti-Cancer Drug Design, 10, 299 (1995).
24. Chaplin D.J., Pettit G.R. and Hill S.A., Anticancer Res., 19, 189 (1999).
25. Dziba J.M., Marcinek R., Venkataraman G., Robinson J.A. and Ain K.B., Thyroid, 12, 1063 (2002).
26. Hua J., Sheng Y., Pinney K.G., Garner C.M., Kane R.R., Prezioso J.A., Pettit G.R., Chaplin D.J. and Edvardsen K., Anticancer Res., 23, 1433 (2003).
27. Pettit G.R. and Rhodes M.R., Anti-Cancer Drug Design, 13, 183 (1998).
28. Kerekes P., Sharma P.N., Brossi A., Chignell C.F. and Quinn F.R., J. Med. Chem., 28, 1204 (1985).
29. Dumont R., Brossi A., Chignell C.F., Quinn F.R. and Suffness M.A., J. Med. Chem., 30, 732 (1987).
30. Hamel E., Ho H.H., Kang G.J. and Lin C.M., Biochem. Pharmacol., 37, 2445 (1988).
31. Muzaffar A., Brossi A., Lin C.M. and Hamel E., J. Med. Chem., 33, 567 (1990).
32. Zavala F., Guenard D., Robin J.P. and Brown E., J. Med. Chem., 23, 546 (1980).
33. Van der Eycken J., Bosmans J.P., Van Haver D., Vandewalle M., Hulkenberg A., Veerman W. and Nieuwenhuizen R., Tetrahedron Lett., 30, 3873 (1989).
34. Klein L.L., Yeung C.M., Chu D.T., McDonald E.J., Clementy J.J. and Plattner J.J., J. Med. Chem., 34, 984 (1991).
35. Wang R.W.J., Rebhun L.I. and Kupchan S.M., Cancer Res., 37, 3071 (1977).
36. Tomioka K., Ishiguro T., Mizuguchi H., Komeshima N., Koga K., Tsukagoshi S., Tsuruo T., Tashiro T., Tanida S. and Kishi T., J. Med. Chem., 34, 54 (1991).
37. Itoh Y., Brossi A., Hamel E. and Lin C.M., Helv. Chim. Acta, 71, 1199 (1988).
38. Batra J.K., Jurd L. and Hamel E., Mol. Pharmacol., 27, 94 (1985).
39. Batra J.K., Kang G.J., Jurd L. and Hamel E., Biochem. Pharmacol., 37, 2595 (1988).
40. Edwards M.L., Stemerick D.M. and Sunkara P.S., J. Med. Chem., 33, 1948 (1990).
41. Lin C.M., Singh S.B., Chu P.S., Dempcy R.O., Schmidt J.M., Pettit GR. and Hamel E., Mol. Pharmacol., 34, 200 (1988).
42. Cushman M., Nagarathnam D., Gopal D., Chakraborti A.K., Lin Ch.M. and Hamel E., J. Med. Chem., 34, 2579 (1991).
43. Cushman M., Nagarathnam D., Gopal D., Hu-Ming He., Lin Ch.M. and Hamel E., J. Med. Chem., 35, 2293 (1992).
44. Xia Y., Yang Z.Y., Xia P., Bastow K.F., Tachibana Y., Kuo S.Ch., Hamel E., Hackl T. and Lee K.H., J. Med. Chem., 41, 1155 (1998).
45. Ohsumi K., Hatanaka T., Fujita K., Nakagawa R., Fukuda Y., Niher Y., Suga Y., Morinaga Y., Akiyama Y. and Tsuji T., Bioorg. Med. Chem. Lett., 8, 3153 (1998).
46. Shirai R., Takayama H., Nishikawa A., Koiso Y. and Hashimoto Y., Bioorg. Med. Chem. Lett., 8, 1997 (1998).
47. Medarde M., Ramos A.C., Caballero E., de Clairac R.P.L., Lopez J.L., Gravalos D.G. and Feliciano A.S., Bioorg. Med. Chem. Lett., 9, 2303 (1999).
48. Gwaltney S.L., Imade H.M., Barr K.J., Li Q., Gehrke L., Credo R.B., Warner R.B., Lee J.Y, Kovar P., Wang J., Nukkala M.A., Zieliński N.A., Frost D., Ng S.C. and Sham H.L., Bioorg. Med. Chem. Lett., 11, 871 (2001).
49. Wang L., Woods K.W., Li Q., Barr K.J., McCroskey R.W., Hannick S.M., Gherke L., Credo R.B., Hui Y.H., Marsh K., Warner R., Lee J.Y., Zieliński-Mozng N., Frost D., Rosenberg S.H. and Sham H.L., J. Med. Chem., 45, 1697 (2002).
50. Orsini F., Pelizzoni F., Bellini B. and Miglierini G., Carbohydr. Res., 301, 95 (1997).
51. Lawrence N.J., Ghani F.A., Hepworth L.A., Hadfield J.A., McGown A.T. and Pritchard R.G., Synthesis, 1656 (1999).
52. Furstner A. and Nikolakis K., Liebigs Ann. Chem., 2107 (1996).
53. Gaukroger K., Hadfield J.A., Hepworth L. A., Lawrence N.J. and McGown A.T., J. Org. Chem., 66, 8135 (2001).
54. Pettit G.R., Lippert J.W., Herald D.L., Hamel E. and Pettit R.K., J. Nat. Prod., 63, 969 (2000).
55. Dark G.G., Hill S.A., Prise V.E., Tozer G.M., Pettit G.R. and Chaplin D.J., Cancer Res., 57, 1829 (1997).
56. Lin C.M., Ho H.H., Pettit G.R. and Hamel E., Biochemistry, 28, 6984 (1989).
57. Pettit G.R., Toki B., Herald D.L., Verdier-Pinard P., Boyd M.R. and Hamel E., J. Med. Chem., 41, 1688 (1998).
58. Iyer S., Chaplin D.J., Rosenthal D.S., Boulares A.H., Li L.Y. and Smulson M.E., Cancer Res., 58, 4510 (1998).
59. Dark G.G., Hill S.A., Prise V.E., Tozer G.M., Pettit G.R. and Chaplin D.J., Cancer Res., 57, 1829 (1997).
60. Tozer G.M., Prise V.E., Wilson J., Locke R.J., Vojnovic B., Stratford M.R., Dennis M.F. and Chaplin D.J., Cancer Res., 59, 1626 (1999).
61. Dzierzbicka K., Kołodziejczyk A.M., Wysocka-Skrzela B., Myśliwski A. and Sosnowska D., J. Med. Chem., 44, 3606 (2001).
62. Sosnowska D., Myśliwski A., Dzierzbicka K. and Kołodziejczyk A., Biotherapy, 10, 161 (1997).
63. Dzierzbicka K. and Kołodziejczyk A.M., J. Med. Chem., 46, 183 (2003).
64. Dzierzbicka K., Trzonkowski P., Sewerynek P. and Myśliwski A., J. Med. Chem., 46, 978 (2003).